Home/ImPact Biotech/Orit Schwartz
OS

Orit Schwartz

Global Head of Technical Operations

ImPact Biotech

Therapeutic Areas

ImPact Biotech Pipeline

DrugIndicationPhase
Padeliporfin VTPUpper Tract Urothelial Carcinoma (UTUC)Phase 1/III